IONSIonis Pharmaceuticals, Inc.
$45.26-26% 1Y
$45.26
$43.3052 weeks$86.50
Is the price fair?
What IONS's price assumes
Ionis Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 14.8× revenue.
14.8
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 29.5
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 29.5
- EV / EBIToperating margin −68%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $12.9B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks